0001179110-20-001670.txt : 20200214 0001179110-20-001670.hdr.sgml : 20200214 20200214185446 ACCESSION NUMBER: 0001179110-20-001670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KWON YOUNG CENTRAL INDEX KEY: 0001733094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 20622622 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS INC. STREET 2: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-02-12 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001733094 KWON YOUNG C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial & Bus. Officer Common Stock 2020-02-12 4 M 0 27500 A 139119 D Common Stock 2020-02-13 4 S 0 9016 30.03 D 130103 D Restricted Stock Units 2020-02-12 4 M 0 27500 0 D Common Stock 27500 0 D Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Restricted Stock Units convert into common stock on a one-for-one basis. Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date. /s/ R.Mark Chamberlin as attorney in fact 2020-02-14